Nicholas J. A. Webb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nicholas J. A. Webb has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Afshin Tavakoli
Renal Transplant Unit Manchester Royal Infirmary Manchester UK
1 shared publicationAllison Birch
Renal Unit Alder Hey Children's NHS Foundation Trust Manchester UK
1 shared publicationDavid V. Milford
Department of Nephrology Birmingham Children's Hospital Manchester UK
1 shared publicationDenise Roberts
Department of Paediatric Nephrology Royal Manchester Children's Hospital Manchester UK
1 shared publicationHany Riad
Renal Transplant Unit, Manchester Royal Infirmary
1 shared publicationMalcolm A. Lewis
Royal Manchester Children’s Hospital
1 shared publication
Latest Publications
- 1 February 2014
- Published by Wiley in Pediatric Transplantation
- Vol. 18 (3) , E74-E76
Successful ABO incompatible renal transplantation following rituximab and DFPP after failed immunoadsorption
Effective antibody removal using PE, DFPP and IA has led to increased access to live donor organs through ABOi RT for patients with chronic kidney disease. However, there have been no head-to-head comparator studies between these modalities, and the choice of technique is usually influenced by cost and institutional preference. We describe the clinical course of a child undergoing ABOi RT, in whom IA without preconditioning with rituximab did not achieve a satisfactory reduction in the antibody titers, who went on to have a successful living donor RT following rituximab and DFPP.
- 1 February 2014
- Published by Wiley in Pediatric Transplantation
- Vol. 18 (3) , E74-E76
Successful ABO incompatible renal transplantation following rituximab and DFPP after failed immunoadsorption
Effective antibody removal using PE, DFPP and IA has led to increased access to live donor organs through ABOi RT for patients with chronic kidney disease. However, there have been no head-to-head comparator studies between these modalities, and the choice of technique is usually influenced by cost and institutional preference. We describe the clinical course of a child undergoing ABOi RT, in whom IA without preconditioning with rituximab did not achieve a satisfactory reduction in the antibody titers, who went on to have a successful living donor RT following rituximab and DFPP.
- 1 March 2009
- Published by Springer Nature in Pediatric Nephrology
- Vol. 24 (3) , 625-626
A single high dose of ergocalciferol can be used to boost 25-hydroxyvitamin D levels in children with kidney disease
- 1 March 2009
- Published by Springer Nature in Pediatric Nephrology
- Vol. 24 (3) , 625-626
A single high dose of ergocalciferol can be used to boost 25-hydroxyvitamin D levels in children with kidney disease
- 1 December 2008
- Published by Springer Nature in Pediatric Nephrology
- Vol. 23 (12) , 2261-2265
Successful renal transplantation in children in the presence of thrombosis of the inferior vena cava
Thrombosis of the inferior vena cava (IVC) has previously been considered to be a contraindication to renal transplantation in children because of the technical difficulties associated with surgery and the increased risk of graft thrombosis. We report three children with previous IVC thrombosis who underwent renal transplantation at our institution over the last 5 years. The pretransplant imaging of these patients included direct venography or magnetic resonance venography to evaluate venous outflow. Two children (19 kg and 36 kg) received deceased donor renal allografts with no surgical complications or delayed graft function. At the latest follow-up 3.0 and 4.6 years posttransplantation, respectively, they were well, with estimated glomerular filtration rates of 52 and 64 ml/min per 1.73 m2, respectively. The third child underwent a live-related-donor renal transplant at the age of 4.9 years (weight 13.5 kg). There was primary graft nonfunction. Renal vein thrombosis was noted on postoperative day 12, with subsequent graft loss. Children with previous IVC thrombosis can be successfully transplanted with adult-sized kidneys provided detailed evaluation of the venous drainage has been performed. There is substantial risk of graft thrombosis, and detailed counselling regarding the specific risks of the procedure is essential.
- 1 December 2008
- Published by Springer Nature in Pediatric Nephrology
- Vol. 23 (12) , 2261-2265
Successful renal transplantation in children in the presence of thrombosis of the inferior vena cava
Thrombosis of the inferior vena cava (IVC) has previously been considered to be a contraindication to renal transplantation in children because of the technical difficulties associated with surgery and the increased risk of graft thrombosis. We report three children with previous IVC thrombosis who underwent renal transplantation at our institution over the last 5 years. The pretransplant imaging of these patients included direct venography or magnetic resonance venography to evaluate venous outflow. Two children (19 kg and 36 kg) received deceased donor renal allografts with no surgical complications or delayed graft function. At the latest follow-up 3.0 and 4.6 years posttransplantation, respectively, they were well, with estimated glomerular filtration rates of 52 and 64 ml/min per 1.73 m2, respectively. The third child underwent a live-related-donor renal transplant at the age of 4.9 years (weight 13.5 kg). There was primary graft nonfunction. Renal vein thrombosis was noted on postoperative day 12, with subsequent graft loss. Children with previous IVC thrombosis can be successfully transplanted with adult-sized kidneys provided detailed evaluation of the venous drainage has been performed. There is substantial risk of graft thrombosis, and detailed counselling regarding the specific risks of the procedure is essential.